130 related articles for article (PubMed ID: 22614045)
1. Identification of a new protein biomarker for colorectal cancer diagnosis.
Zhai XH; Yu JK; Yang FQ; Zheng S
Mol Med Rep; 2012 Aug; 6(2):444-8. PubMed ID: 22614045
[TBL] [Abstract][Full Text] [Related]
2. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.
Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S
Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854
[TBL] [Abstract][Full Text] [Related]
3. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
[TBL] [Abstract][Full Text] [Related]
4. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
Liu C; Pan C; Shen J; Wang H; Yong L
Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268
[TBL] [Abstract][Full Text] [Related]
5. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
[TBL] [Abstract][Full Text] [Related]
6. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
[TBL] [Abstract][Full Text] [Related]
7. Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.
Wang Q; Shen J; Li ZF; Jie JZ; Wang WY; Wang J; Zhang ZT; Li ZX; Yan L; Gu J
BMC Cancer; 2009 Aug; 9():287. PubMed ID: 19689818
[TBL] [Abstract][Full Text] [Related]
8. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
[TBL] [Abstract][Full Text] [Related]
9. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
[TBL] [Abstract][Full Text] [Related]
10. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
[TBL] [Abstract][Full Text] [Related]
12. Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer.
Albrethsen J; Bøgebo R; Møller CH; Olsen JA; Raskov HH; Gammeltoft S
Proteomics Clin Appl; 2012 Apr; 6(3-4):182-9. PubMed ID: 22532454
[TBL] [Abstract][Full Text] [Related]
13. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
[TBL] [Abstract][Full Text] [Related]
14. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
15. Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
Huijbers A; Mesker WE; Mertens BJ; Bladergroen MR; Deelder AM; van der Burgt YE; Tollenaar RA
Colorectal Dis; 2014 Nov; 16(11):907-13. PubMed ID: 25243779
[TBL] [Abstract][Full Text] [Related]
16. Detection and identification of potential biomarkers of breast cancer.
Fan Y; Wang J; Yang Y; Liu Q; Fan Y; Yu J; Zheng S; Li M; Wang J
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1243-54. PubMed ID: 20237941
[TBL] [Abstract][Full Text] [Related]
17. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer.
Fan NJ; Kang R; Ge XY; Li M; Liu Y; Chen HM; Gao CF
Diagn Pathol; 2014 Mar; 9():53. PubMed ID: 24618180
[TBL] [Abstract][Full Text] [Related]
18. Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients.
Duan B; Bai J; Qiu J; Wang J; Tong C; Wang X; Miao J; Li Z; Li W; Yang J; Huang C
EBioMedicine; 2018 Nov; 37():134-143. PubMed ID: 30361067
[TBL] [Abstract][Full Text] [Related]
19. Low-mass-ion discriminant equation: a new concept for colorectal cancer screening.
Lee JH; Kim KH; Park JW; Chang HJ; Kim BC; Kim SY; Kim KG; Lee ES; Kim DY; Oh JH; Yoo BC; Kim IH
Int J Cancer; 2014 Apr; 134(8):1844-53. PubMed ID: 24096867
[TBL] [Abstract][Full Text] [Related]
20. Metabonomics identifies serum metabolite markers of colorectal cancer.
Tan B; Qiu Y; Zou X; Chen T; Xie G; Cheng Y; Dong T; Zhao L; Feng B; Hu X; Xu LX; Zhao A; Zhang M; Cai G; Cai S; Zhou Z; Zheng M; Zhang Y; Jia W
J Proteome Res; 2013 Jun; 12(6):3000-9. PubMed ID: 23675754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
